INS and type 2 diabetes mellitus: Furthermore, the reduction of glucotoxicity with some glucose-lowering drugs restored the expression of incretin receptors in diabetic animals [9, 10] and improved incretin-induced insulin secretion in subjects with type 2 diabetes [11].